| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.006 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.12 | 0.02 |